Interpreting LFTs in cancer patients involves considering the context of the patient's overall health and cancer type. Elevated ALT and AST levels could indicate liver damage from metastasis or treatment toxicity. High ALP and GGT levels might suggest obstruction or liver metastasis. Elevated bilirubin could indicate severe liver dysfunction or bile duct obstruction. It's essential to correlate LFT results with imaging studies and clinical findings for accurate diagnosis and management.
